Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Incidental Detection of Asymptomatic Brain Metastases Due to Carcinoma Prostate in Ga-68 PSMA HBED-CC Positron Emission Tomography-Computed Tomography: Reiterating its Superiority in Assessing Disease Status.

Literature DB >> 35478671

Incidental Detection of Asymptomatic Brain Metastases Due to Carcinoma Prostate in Ga-68 PSMA HBED-CC Positron Emission Tomography-Computed Tomography: Reiterating its Superiority in Assessing Disease Status.

Harihara Sudhan Nellaiappan¹, Vishnukumar Rajaraman¹, Dhanapathi Halanaik¹, Ramesh Ananthakrrishnan².

Abstract

Brain metastasis originating in adenocarcinoma of the prostate is rare and can be expected in cases of disseminated bone and soft-tissue disease. Asymptomatic brain metastasis is rare at any point of the disease stage. Ga-68 PSMA positron emission tomography-computed tomography (PET-CT) is one of the useful investigations for assessing the disease status in adenocarcinoma of the prostate. We report a case of asymptomatic brain metastases detected in Ga-68 PSMA PET-CT scan. Copyright:

Entities: Chemical

Keywords: 68Ga-PSMA; PSMA-RADS; brain metastasis; prostate carcinoma

Year: 2022 PMID： 35478671 PMCID： PMC9037885 DOI： 10.4103/ijnm.ijnm_100_21

Source DB: PubMed Journal: Indian J Nucl Med ISSN： 0974-0244

Keyword Cloud
References

13 in total

Review 1. Molecular Imaging for Primary Staging of Prostate Cancer.

Authors: Kelsey L Pomykala; Andrea Farolfi; Boris Hadaschik; Wolfgang P Fendler; Ken Herrmann
Journal: Semin Nucl Med Date: 2019-03-20 Impact factor: 4.446

Review 2. Gallium-68 Prostate-Specific Membrane Antigen PET Imaging.

Authors: Michael S Hofman; Amir Iravani
Journal: PET Clin Date: 2017-02-01

3. PSMA-RADS Version 1.0: A Step Towards Standardizing the Interpretation and Reporting of PSMA-targeted PET Imaging Studies.

Authors: Steven P Rowe; Kenneth J Pienta; Martin G Pomper; Michael A Gorin
Journal: Eur Urol Date: 2017-11-11 Impact factor: 20.096

Review 4. Prostate-Specific Membrane Antigen PET/Magnetic Resonance Imaging for the Planning of Salvage Radiotherapy in Patients with Prostate Cancer with Biochemical Recurrence After Radical Prostatectomy.

Authors: Mattijs Elschot; Kirsten Margrete Selnæs; Sverre Langørgen; Håkon Johansen; Helena Bertilsson; Torgrim Tandstad; Tone Frost Bathen
Journal: PET Clin Date: 2019-08-02

5. Brain metastases from prostate cancer: an 11-year analysis in the MRI era with emphasis on imaging characteristics, incidence, and prognosis.

Authors: Vaios Hatzoglou; Gita V Patel; Michael J Morris; Kristen Curtis; Zhigang Zhang; Weiji Shi; Jason Huse; Marc Rosenblum; Andrei I Holodny; Robert J Young
Journal: J Neuroimaging Date: 2012-12-28 Impact factor: 2.486

Incidental Detection of Asymptomatic Brain Metastases Due to Carcinoma Prostate in Ga-68 PSMA HBED-CC Positron Emission Tomography-Computed Tomography: Reiterating its Superiority in Assessing Disease Status.

Review 1. Molecular Imaging for Primary Staging of Prostate Cancer.

Review 2. Gallium-68 Prostate-Specific Membrane Antigen PET Imaging.

3. PSMA-RADS Version 1.0: A Step Towards Standardizing the Interpretation and Reporting of PSMA-targeted PET Imaging Studies.

Review 4. Prostate-Specific Membrane Antigen PET/Magnetic Resonance Imaging for the Planning of Salvage Radiotherapy in Patients with Prostate Cancer with Biochemical Recurrence After Radical Prostatectomy.

5. Brain metastases from prostate cancer: an 11-year analysis in the MRI era with emphasis on imaging characteristics, incidence, and prognosis.

6. Parenchymal brain metastases from adenocarcinoma of prostate.

7. Prostate Cancer Brain Metastases: A Single-Institution Experience.

Review 8. Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer.

9. Isolated brain metastasis of prostate carcinoma in the setting of normal prostate specific antigen.